259 related articles for article (PubMed ID: 25911106)
1. Redox Control of Protein Arginine Methyltransferase 1 (PRMT1) Activity.
Morales Y; Nitzel DV; Price OM; Gui S; Li J; Qu J; Hevel JM
J Biol Chem; 2015 Jun; 290(24):14915-26. PubMed ID: 25911106
[TBL] [Abstract][Full Text] [Related]
2. Understanding protein arginine methyltransferase 1 (PRMT1) product specificity from molecular dynamics.
Gathiaka S; Boykin B; Cáceres T; Hevel JM; Acevedo O
Bioorg Med Chem; 2016 Oct; 24(20):4949-4960. PubMed ID: 27545444
[TBL] [Abstract][Full Text] [Related]
3. A protein arginine N-methyltransferase 1 (PRMT1) and 2 heteromeric interaction increases PRMT1 enzymatic activity.
Pak ML; Lakowski TM; Thomas D; Vhuiyan MI; Hüsecken K; Frankel A
Biochemistry; 2011 Sep; 50(38):8226-40. PubMed ID: 21851090
[TBL] [Abstract][Full Text] [Related]
4. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C
Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289
[TBL] [Abstract][Full Text] [Related]
5. Cholecalciferol and metformin protect against lipopolysaccharide-induced endothelial dysfunction and senescence by modulating sirtuin-1 and protein arginine methyltransferase-1.
Raj V; Natarajan S; C M; Chatterjee S; Ramasamy M; Ramanujam GM; Arasu MV; Al-Dhabi NA; Choi KC; Arockiaraj J; Karuppiah K
Eur J Pharmacol; 2021 Dec; 912():174531. PubMed ID: 34710370
[TBL] [Abstract][Full Text] [Related]
6. A remodeled protein arginine methyltransferase 1 (PRMT1) generates symmetric dimethylarginine.
Gui S; Gathiaka S; Li J; Qu J; Acevedo O; Hevel JM
J Biol Chem; 2014 Mar; 289(13):9320-7. PubMed ID: 24478314
[TBL] [Abstract][Full Text] [Related]
7. Deep Protein Methylation Profiling by Combined Chemical and Immunoaffinity Approaches Reveals Novel PRMT1 Targets.
Hartel NG; Chew B; Qin J; Xu J; Graham NA
Mol Cell Proteomics; 2019 Nov; 18(11):2149-2164. PubMed ID: 31451547
[TBL] [Abstract][Full Text] [Related]
8. Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs.
Dhar S; Vemulapalli V; Patananan AN; Huang GL; Di Lorenzo A; Richard S; Comb MJ; Guo A; Clarke SG; Bedford MT
Sci Rep; 2013; 3():1311. PubMed ID: 23419748
[TBL] [Abstract][Full Text] [Related]
9. Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization.
Dillon MB; Bachovchin DA; Brown SJ; Finn MG; Rosen H; Cravatt BF; Mowen KA
ACS Chem Biol; 2012 Jul; 7(7):1198-204. PubMed ID: 22506763
[TBL] [Abstract][Full Text] [Related]
10. Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively.
Kölbel K; Ihling C; Bellmann-Sickert K; Neundorf I; Beck-Sickinger AG; Sinz A; Kühn U; Wahle E
J Biol Chem; 2009 Mar; 284(13):8274-82. PubMed ID: 19158082
[TBL] [Abstract][Full Text] [Related]
11. Protein arginine methylation of SERBP1 by protein arginine methyltransferase 1 affects cytoplasmic/nuclear distribution.
Lee YJ; Hsieh WY; Chen LY; Li C
J Cell Biochem; 2012 Aug; 113(8):2721-8. PubMed ID: 22442049
[TBL] [Abstract][Full Text] [Related]
12. PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation.
Tang J; Gary JD; Clarke S; Herschman HR
J Biol Chem; 1998 Jul; 273(27):16935-45. PubMed ID: 9642256
[TBL] [Abstract][Full Text] [Related]
13. Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
Hu H; Luo C; Zheng YG
J Biol Chem; 2016 Dec; 291(52):26722-26738. PubMed ID: 27834681
[TBL] [Abstract][Full Text] [Related]
14. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases.
Böger RH; Sydow K; Borlak J; Thum T; Lenzen H; Schubert B; Tsikas D; Bode-Böger SM
Circ Res; 2000 Jul; 87(2):99-105. PubMed ID: 10903992
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4.
Lakowski TM; Frankel A
Biochem J; 2009 Jun; 421(2):253-61. PubMed ID: 19405910
[TBL] [Abstract][Full Text] [Related]
16. Activity-based protein profiling of protein arginine methyltransferase 1.
Obianyo O; Causey CP; Jones JE; Thompson PR
ACS Chem Biol; 2011 Oct; 6(10):1127-35. PubMed ID: 21838253
[TBL] [Abstract][Full Text] [Related]
17. Reduced asymmetric dimethylarginine accumulation through inhibition of the type I protein arginine methyltransferases promotes renal fibrosis in obstructed kidneys.
Wu M; Lin P; Li L; Chen D; Yang X; Xu L; Zhou B; Wang C; Zhang Y; Luo C; Ye C
FASEB J; 2019 Jun; 33(6):6948-6956. PubMed ID: 30840839
[TBL] [Abstract][Full Text] [Related]
18. Naturally occurring cancer-associated mutations disrupt oligomerization and activity of protein arginine methyltransferase 1 (PRMT1).
Price OM; Thakur A; Ortolano A; Towne A; Velez C; Acevedo O; Hevel JM
J Biol Chem; 2021 Nov; 297(5):101336. PubMed ID: 34688662
[TBL] [Abstract][Full Text] [Related]
19. Protein arginine methyltransferase 1: positively charged residues in substrate peptides distal to the site of methylation are important for substrate binding and catalysis.
Osborne TC; Obianyo O; Zhang X; Cheng X; Thompson PR
Biochemistry; 2007 Nov; 46(46):13370-81. PubMed ID: 17960915
[TBL] [Abstract][Full Text] [Related]
20. Screening of substrates of protein arginine methyltransferase 1 in glioma.
Wang S; Tan XC; Yang B; Yin B; Peng XZ
Chin Med Sci J; 2012 Mar; 27(1):1-6. PubMed ID: 22734206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
